Form D — Epicrispr Biotechnologies, Inc.
0002151604-26-000001 · filed Aug 26, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $212,755,230
- Total sold
- $176,754,406
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Epicrispr Biotechnologies, Inc.
- CIK
- 2151604
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 7000 SHORELINE COURT, STE 100
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 510-934-7574
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Amber Salzman · Executive OfficerSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Haorui Zhang · Executive OfficerSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Lei Qi · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Andrew Lam · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Jennifer King · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Eric Crombez · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
-
Anran Li · DirectorSOUTH SAN FRANCISCO, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗